Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > publication from Dr McFarland's team - Dec 9

<< Previous

Bullboard Posts

Next >>

Comment by menoalittleon Dec 10, 2021 12:20pm

494 Views

Post# 34219000

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:publication from Dr McFarland's team - Dec 9

guess I didn't think it was rocket science to understand what was written in the patent... lol.

but, perhaps it's that lack of grasping the relatively obvious that's exactly why this stock hasn't actually moved up as fast or as high as some of us might have been expecting

<< Previous

Bullboard Posts

Next >>

Critical raw materials pioneer drives Europe’s clean energy transition